LT2994160T - Alzheimerio ligos pogrupių gydymas su iš kelių donorų sumaišytu imunoglobulinu g - Google Patents
Alzheimerio ligos pogrupių gydymas su iš kelių donorų sumaišytu imunoglobulinu gInfo
- Publication number
- LT2994160T LT2994160T LTEP14730660.9T LT14730660T LT2994160T LT 2994160 T LT2994160 T LT 2994160T LT 14730660 T LT14730660 T LT 14730660T LT 2994160 T LT2994160 T LT 2994160T
- Authority
- LT
- Lithuania
- Prior art keywords
- alzheimer
- treatment
- pooled immunoglobulin
- subpopulations
- disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940027941 immunoglobulin g Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361855062P | 2013-05-06 | 2013-05-06 | |
| US201361833447P | 2013-06-10 | 2013-06-10 | |
| US201361844732P | 2013-07-10 | 2013-07-10 | |
| US201361886464P | 2013-10-03 | 2013-10-03 | |
| PCT/US2014/036848 WO2014182631A1 (en) | 2013-05-06 | 2014-05-05 | Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2994160T true LT2994160T (lt) | 2019-08-26 |
Family
ID=50943566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP14730660.9T LT2994160T (lt) | 2013-05-06 | 2014-05-05 | Alzheimerio ligos pogrupių gydymas su iš kelių donorų sumaišytu imunoglobulinu g |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20140328856A1 (enExample) |
| EP (2) | EP2994160B1 (enExample) |
| JP (1) | JP6424210B2 (enExample) |
| AU (4) | AU2014262890B2 (enExample) |
| DK (1) | DK2994160T3 (enExample) |
| ES (1) | ES2740127T3 (enExample) |
| HR (1) | HRP20191383T1 (enExample) |
| HU (1) | HUE044737T2 (enExample) |
| LT (1) | LT2994160T (enExample) |
| PL (1) | PL2994160T3 (enExample) |
| PT (1) | PT2994160T (enExample) |
| WO (1) | WO2014182631A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4289820A3 (en) | 2014-03-21 | 2024-03-13 | Alzheon, Inc. | Compounds for use in treating alzheimer's disease in apoe4+/+ patients |
| WO2016033382A1 (en) * | 2014-08-27 | 2016-03-03 | Capnia, Inc. | Methods for immune globulin administration |
| MA41115A (fr) | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
| JP6789579B2 (ja) * | 2015-09-10 | 2020-11-25 | アルジオン， インコーポレイテッド | 特定の患者集団において神経変性障害を処置する方法 |
| CN114019170A (zh) * | 2016-01-20 | 2022-02-08 | 基因泰克公司 | 用于阿尔茨海默氏病的高剂量治疗 |
| HRP20211628T1 (hr) * | 2016-08-18 | 2022-02-04 | Alkahest, Inc. | Frakcije krvne plazme kao tretman za kongitivne poremećaje povezane sa starenjem |
| BR112019022402A2 (pt) * | 2017-04-26 | 2020-05-19 | Alkahest Inc | regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo |
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| SI3672631T1 (sl) | 2017-08-22 | 2023-06-30 | Biogen Ma Inc. | Farmacevtski sestavki, ki vsebujejo protitelesa proti beta amiloidu |
| FI128916B (en) * | 2018-02-05 | 2021-03-15 | Vetcare Oy | Health-promoting composition and method for its preparation |
| KR102276545B1 (ko) * | 2019-09-05 | 2021-07-15 | 고려대학교 산학협력단 | Ct 영상 기반 부위별 대뇌 피질 수축율 예측 방법 및 장치 |
| NL2024431B1 (en) | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
| US12281166B2 (en) | 2020-05-26 | 2025-04-22 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking Galectin-3 |
| CA3198827A1 (en) * | 2020-10-30 | 2022-05-05 | Rush University Medical Center | Intranasal immunotherapy for the treatment of alzheimer's disease |
| EP4472679A1 (en) * | 2022-02-03 | 2024-12-11 | Eli Lilly and Company | Regional tau imaging for diagnosing and treating alzheimer's disease |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE348942B (enExample) | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
| US5624898A (en) | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
| US6585957B1 (en) | 2000-01-25 | 2003-07-01 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
| WO2003028668A2 (en) | 2001-10-04 | 2003-04-10 | Protein Therapeutics, Inc. | Gammaglobulin treatment of immune disorders |
| US20090136505A1 (en) | 2005-02-23 | 2009-05-28 | Johanna Bentz | Intranasal Administration of Active Agents to the Central Nervous System |
| WO2006091332A2 (en) | 2005-02-23 | 2006-08-31 | Alza Corporation | Intranasal administration of active agents to the central nervous system |
| PL1981540T3 (pl) * | 2006-01-30 | 2013-08-30 | Grifols Therapeutics Inc | Sposób leczenia i profilaktyki chorób związanych z odkładaniem się amyloidu z zastosowaniem IgM |
| JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| TWI489994B (zh) | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
| US9084743B2 (en) | 2009-09-17 | 2015-07-21 | Baxter International Inc. | Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| US8622993B2 (en) | 2009-12-18 | 2014-01-07 | Healthpartners Research Foundation | Device and method for delivering therapeutic substances to the maxillary sinus of a patient |
| SG184820A1 (en) * | 2010-04-13 | 2012-11-29 | Baxter Int | Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease |
| WO2011142778A1 (en) * | 2010-05-13 | 2011-11-17 | The University Of Kentucky Research Foundation | Treatment of mci and alzheimer's disease |
| JP6055412B2 (ja) * | 2010-09-17 | 2016-12-27 | バクスアルタ ゲーエムベーハー | 弱酸性〜中性のｐＨにおける、ヒスチジンを有する水性製剤を介した免疫グロブリンの安定化 |
| KR20130139153A (ko) * | 2011-01-18 | 2013-12-20 | 백스터 인터내셔널 인코포레이티드 | 인간 혈액 중 항-베타 아밀로이드 항체의 측정 |
| US20120251524A1 (en) * | 2011-04-01 | 2012-10-04 | Baxter Healthcare S.A. | Use of cytokine levels in intravenous immunoglobulin treatment of alzheimer's disease |
| ES2714999T3 (es) * | 2011-09-24 | 2019-05-31 | Csl Behring Gmbh | Terapia de combinación que usa inmunoglobulina e inhibidor de C1 |
-
2014
- 2014-05-05 AU AU2014262890A patent/AU2014262890B2/en active Active
- 2014-05-05 EP EP14730660.9A patent/EP2994160B1/en active Active
- 2014-05-05 ES ES14730660T patent/ES2740127T3/es active Active
- 2014-05-05 PL PL14730660T patent/PL2994160T3/pl unknown
- 2014-05-05 WO PCT/US2014/036848 patent/WO2014182631A1/en not_active Ceased
- 2014-05-05 LT LTEP14730660.9T patent/LT2994160T/lt unknown
- 2014-05-05 HR HRP20191383TT patent/HRP20191383T1/hr unknown
- 2014-05-05 US US14/270,192 patent/US20140328856A1/en not_active Abandoned
- 2014-05-05 JP JP2016512995A patent/JP6424210B2/ja active Active
- 2014-05-05 HU HUE14730660 patent/HUE044737T2/hu unknown
- 2014-05-05 EP EP19175106.4A patent/EP3552624A1/en active Pending
- 2014-05-05 DK DK14730660.9T patent/DK2994160T3/da active
- 2014-05-05 PT PT14730660T patent/PT2994160T/pt unknown
-
2019
- 2019-01-14 US US16/247,141 patent/US20190144530A1/en not_active Abandoned
- 2019-04-09 AU AU2019202459A patent/AU2019202459B2/en active Active
-
2020
- 2020-10-19 AU AU2020257034A patent/AU2020257034A1/en not_active Abandoned
-
2021
- 2021-04-19 US US17/234,658 patent/US20210238267A1/en not_active Abandoned
-
2024
- 2024-02-19 AU AU2024201051A patent/AU2024201051A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014262890A1 (en) | 2015-11-26 |
| PL2994160T3 (pl) | 2019-10-31 |
| JP6424210B2 (ja) | 2018-11-14 |
| AU2019202459A1 (en) | 2019-05-02 |
| AU2024201051A1 (en) | 2024-03-14 |
| HRP20191383T1 (hr) | 2020-02-07 |
| ES2740127T3 (es) | 2020-02-05 |
| DK2994160T3 (da) | 2019-08-12 |
| US20140328856A1 (en) | 2014-11-06 |
| US20210238267A1 (en) | 2021-08-05 |
| EP2994160B1 (en) | 2019-07-03 |
| AU2020257034A1 (en) | 2020-11-12 |
| WO2014182631A1 (en) | 2014-11-13 |
| EP3552624A1 (en) | 2019-10-16 |
| EP2994160A1 (en) | 2016-03-16 |
| AU2014262890B2 (en) | 2019-01-31 |
| JP2016518411A (ja) | 2016-06-23 |
| US20190144530A1 (en) | 2019-05-16 |
| HUE044737T2 (hu) | 2019-11-28 |
| AU2019202459B2 (en) | 2020-07-23 |
| PT2994160T (pt) | 2019-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2994160T (lt) | Alzheimerio ligos pogrupių gydymas su iš kelių donorų sumaišytu imunoglobulinu g | |
| EP2945538A4 (en) | FITNESS MONITOR | |
| IL241101A0 (en) | Medicinal uses of empagliflozin | |
| HUE056006T2 (hu) | Kombináció Parkinson-kór kezelésére | |
| EP2951139A4 (en) | SYNTHESIS FROM 1,1,2,3-TETRACHLORPROPENE | |
| HUE060721T2 (hu) | Empagliflozin terápiás alkalmazásai | |
| HUE041709T2 (hu) | Az empagliflozin terápiás alkalmazásai | |
| DK2764881T3 (da) | System til medicinsk behandling | |
| PT3626270T (pt) | Tratamento de doenças cardiovasculares | |
| LT3007726T (lt) | Tautopatijos gydymo būdai | |
| HUE067687T2 (hu) | Melegsajtolt alkatrészek feldolgozása | |
| SI3563837T1 (sl) | Bakteriofagna terapija | |
| SG10201705899XA (en) | Prevention & treatment of neuropathy | |
| EP2966074A4 (en) | morphinan | |
| PL3016977T3 (pl) | Ludzkie przeciwciała anty-IL-32 | |
| SI2986325T1 (sl) | Postopki zdravljenja motenj ciklusa sečnine | |
| GB201302878D0 (en) | Modified igG molecules | |
| EP2958454A4 (en) | MAGNETOTHERAPEUTIC BAND | |
| DK2976101T3 (da) | Behandlingsfremgangsmåde | |
| HK40097140A (zh) | 治疗线粒体疾病的方法 | |
| DK3041506T3 (da) | Behandlingsfremgangsmåde | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| HK40032828A (en) | Methods for the treatment of mitochondrial disease | |
| GB201321628D0 (en) | Treatment of disease | |
| GB201317785D0 (en) | Novel healthcare diagnostic method |